Erythromelalgia: Introduction

  • Erythromelalgia is a rare condition that primarily affects the feet and it is characterized by intense, burning pain of affected extremities, severe redness (erythema), and increased skin temperature that may be episodic or almost continuous in nature
  • The specific cause of erythromelalgia remains unknown. Erythromelalgia is a result of vasomotor abnormalities or dysfunction in the normal narrowing and widening of the diameter of certain blood vessels, leading to abnormalities of blood flow to the extremities.
  • Females are more affected than males. Disorder onset occurs most commonly in middle age; however, associated symptoms may develop at any age. Erythromelalgia is of two types: primary Erythromelalgia and Secondary Erythromelalgia.

Key Drivers of Global Erythromelalgia Treatment Market

  • Increase in number of patients with erythromelalgia, strong product pipeline, and increasing research & development activity for developing new innovative drugs for treatment of erythromelalgia are likely to drive the erythromelalgia market during the forecast period. In addition, high demand for disease specific novel treatment to the patients as quickly as possible is enhancing the growth of the market.
  • According to the National Organization for Rare Disorders, prevalence rate of erythromelalgia is approximately 1.3 people in every 100,000 people in the U.S.
  • On the other hand, limited treatment options and low healthcare budget in some developing countries are likely to restrain the growth of the market

Request a Sample to Get Extensive Insights into the Erythromelalgia Treatment Market

Primary Erythromelalgia Segment Expected to be Most Promising Segment

  • Based on type, the global erythromelalgia treatment market can be segmented into primary erythromelalgia and secondary erythromelalgia
  • The primary erythromelalgia segment accounted for the highest share of the erythromelalgia treatment market in 2019. This segment is expected to dominate the erythromelalgia treatment market due to high number of patients with erythromelalgia disease.

Drug Segment to Witness Significant Growth

  • In terms of treatment type, the global erythromelalgia treatment market can be divided into drug, and surgery. The drug segment is further divided into mexiletine, gabapentin, lidocaine, aspirin, and others.
  • The drug segment generated the highest revenue in 2019 and is anticipated to witness growth during the forecast period. This can be attributed to strong product pipeline for treatment of erythromelalgia from major manufacturers. Currently, Teva Pharmaceutical Industries Ltd. and Xenon Pharmaceuticals signed a collaboration to develop new product (XEN402) for treatment of erythromelalgia, which is in phase 2.  

Oral Product Segment to Witness High Demand

  • Based on route of administration, the global erythromelalgia treatment market can be segmented into oral and topical 
  • The oral segment accounted for the highest share of the topical wound agents market in 2019. This segment is expected to dominate the topical wound agents market due to most of the products available in tablet and capsule form and which is more effective as compared to topical dosage form.

Hospitals Pharmacies Segment to be Most Promising Segment

  • In terms of distribution channel, the global erythromelalgia treatment market can be divided into hospital pharmacies, retail pharmacies, and online sales. The retail pharmacies segment generated the highest revenue in 2019 and is anticipated to witness growth during the forecast period due to most of major products are generic products, which is easily available in retail pharmacies.

Looking for Customized Insights to build your Business for Future, Ask for a Custom Report here

North America to Dominate Global Erythromelalgia Treatment Market

  • In terms of region, the global erythromelalgia treatment market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global erythromelalgia treatment market in 2019 and is expected to maintain its leading position during the forecast period. This dominance of the region can be attributed to increasing research & development activity from major market players, increase in product offerings, greater affordability, and rise in demand for early treatment.
  • The market in Asia Pacific is projected to register highest growth during the forecast period, owing to increase in adoption of new products and rise in demand for erythromelalgia treatment in emerging countries such as India and China

Key Manufacturers Operating in Global Market

The global erythromelalgia treatment market was highly fragmented in 2019. Key manufacturers operating in the global market are:

  • Teva Pharmaceutical Industries Ltd
  •  Biogen
  • Pfizer Inc.
  • Akorn
  • Novartis AG
  • Galderma Laboratories, L.P
  • Acorda Therapeutics, Inc.
  • Allergan plc
  • Amneal Pharmaceuticals LLC.

Erythromelalgia Treatment Market: Research Scope

Erythromelalgia Treatment Market, by Type

  • Primary Erythromelalgia
  • Secondary Erythromelalgia

Erythromelalgia Treatment Market, by Treatment Type

  • Drug
    • Mexiletine
    • Gabapentin
    • Lidocaine
    • Aspirin
    • Others
  • Surgery

Erythromelalgia Treatment Market, by Route of Administration

  • Oral
  • Topical

Erythromelalgia Treatment Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales

Erythromelalgia Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Erythromelalgia Treatment Market

Pre Book